TG Therapeutics TGTX Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| License | $11.77M+237% | $9.36M-38.7% | $6.74M-55.9% | $4.93M-96.8% | $3.49M-97.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does TG Therapeutics break its business down?
- TG Therapeutics (TGTX) reports revenue by product across 2 parts — License and License Revenue. Each is extracted from the segment footnotes and tracked over time.
- Where does TG Therapeutics's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in TG Therapeutics's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
